Literature DB >> 3542298

Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage.

H Arnqvist, P O Olsson, H von Schenck.   

Abstract

We evaluated results of radioimmunoassays of free and total insulin after precipitation of endogenous antibodies with polyethylene glycol (PEG), and we investigated the influence of collection time, temperature, and storage in heparin- cr EDTA-treated plasma or serum on results for free insulin. Analytical recovery of free insulin was 99.3%, of total insulin 96.4%. For free insulin, assay precision (CV) was 4.0-13.0% (intra-assay) and 7.8-10.7% (inter-assay); for total insulin, 3.6-9.5% and 6.6-11.7%, respectively. Free insulin decreased in plasma (p less than 0.05) and serum (p less than 0.01) at room temperature after 3 h and in promptly analyzed serum (p less than 0.01). Storage of samples at -20 degrees C increased the concentration of free insulin in plasma (p less than 0.025) and serum (p less than 0.005), whereas the free insulin content of supernates after PEG precipitation was stable, except for a slight decrease in serum samples (p less than 0.02). We conclude that, for radioimmunoassay of free and total insulin, plasma should be used, treated with PEG without delay; supernates then are analytically stable for as long as 26 weeks at -20 degrees C.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3542298

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Pancreatic exocrine and endocrine function in patients with pancreas divisum and abdominal pain.

Authors:  E Lindström; H von Schenck; I Ihse
Journal:  Int J Pancreatol       Date:  1990-01

2.  Pancreatic ductal morphology and function in primary Sjögren's syndrome.

Authors:  E Lindström; F Lindström; H von Schenck; I Ihse
Journal:  Int J Pancreatol       Date:  1991-02

3.  Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.

Authors:  R Giannarelli; P Marchetti; M Giannecchini; G Di Cianni; P Cecchetti; A Masoni; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

Review 4.  Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulation.

Authors:  Marian Kelley; Ago B Ahene; Boris Gorovits; John Kamerud; Lindsay E King; Thomas McIntosh; Jihong Yang
Journal:  AAPS J       Date:  2013-03-30       Impact factor: 4.009

5.  Efficacy determinants of subcutaneous microdose glucagon during closed-loop control.

Authors:  Steven J Russell; Firas H El-Khatib; David M Nathan; Edward R Damiano
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

6.  Effect of different types of high carbohydrate diets on glycogen metabolism in liver and skeletal muscle of endurance-trained rats.

Authors:  G Garrido; M Guzmán; J M Odriozola
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  Effects of brewer's yeast on glucose tolerance and serum lipids in Chinese adults.

Authors:  Y C Li
Journal:  Biol Trace Elem Res       Date:  1994-06       Impact factor: 3.738

8.  Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Sjöberg; B L Johansson; J Ostman; J Wahren
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

9.  Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.

Authors:  Catherine B Renard; Farah Kramer; Fredrik Johansson; Najib Lamharzi; Lisa R Tannock; Matthias G von Herrath; Alan Chait; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients.

Authors:  B L Johansson; B Linde; J Wahren
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.